Rua Bioscience Limited (NZX:RUA) Annual Report 2022



The latest annual report of Rua Bioscience Limited (RUA) was published on 30 Jun 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - RUA Annual Results

Amounts in NZD

Total Revenue
645.1k
Gross Profit
516.45k
EBIT
-7.58M
Net Tangible Assets
8.73M
Net Income
-8.64M
Capital Expenditures
-400.1k

RUA Income Statement 2022 Annual Report

As per the latest Income Statement of RUA, the Net revenue increased by $285760 (80%) compared to the previous period. The operating income in 2022 decreased by $-1.30M (-21%). The net income as per the annual report was -8.64M which decreased by $-4.22M (-95%) compared to previous year.

Income Statement Report (2022/2021)

2022 2021
Total Revenue 645.1k 359.33k
Gross Profit 516.45k 359.33k
Operating Income -7.58M -6.28M
Income Before Tax -7.49M -6.17M
Net Income -8.64M -4.42M

Balance Sheet - RUA 2022 Annual Report

Read further: RUA Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Rua Bioscience Limited showed the company reduced the cash on balance sheet by $-1.46M (-44%). The Net tangible assets of RUA on the balance sheet were at 8.73M which is $-16.10M (-65%) less than previous annual report. The total stockholder equity also decreased by $-4.64M (-16%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

2022 2021
Cash 1.9M 3.36M
Total Assets 33.57M 30.85M
Long Term Debt - -
Total Liabilities 9.38M 2.02M
Total Shareholder Equity 24.2M 28.83M
Net Tangible Assets 8.73M 24.83M

Cash Flow Statement - RUA 2022 Annual Report

The 2022 annual cash flow statement of Rua Bioscience Limited showed that the net income decreased by $-4.22M (-95%) compared to previous reporting period. Also the capital expenditure of RUA increased by $1.00M (71%).

As of 2022, the total cash from investing activities was 5.59M and total cash from financing activities was -208.64k.

Cash Flow Statement Report (2022/2021)

2022 2021
Net Income -8.64M -4.42M
Capital Expenditures -400.1k -1.4M
Dividends Paid - -
Total Cash From From Investing Activities 5.59M -14.43M
Total Cash From From Financing Activities -208.64k 18.3M

Rua Bioscience Limited Annual Report History

Income Statement

Income Statement history of Rua Bioscience Limited (NZX:RUA)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Total Revenue 645.1k 359.33k - 221.91k
Cost Of Revenue 128.64k - - -
Gross Profit 516.45k 359.33k - 221.91k
Research Development 2.98M 1.9M 1.29M 818.73k
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses 5.12M 4.74M 3.05M 1.44M
Total Operating Expenses 8.23M 6.64M 4.34M 2.26M
Operating Income -7.58M -6.28M -4.34M -2.04M
Total Other Income Expense Net 98.33k 107.64k 745.91k 53.75k
Ebit -7.58M -6.28M -4.34M -2.04M
Interest Expense -40.82k -31.56k -17.75k -5.74k
Income Before Tax -7.49M -6.17M -3.6M -1.98M
Income Tax Expense 1.15M -1.76M -784.52k -13.69k
Minority Interest - - - -
Net Income From Continuing Ops -8.64M -4.42M -2.81M -1.97M
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income -8.64M -4.42M -2.81M -1.97M
Net Income Applicable To Common Shares -8.64M -4.42M -2.81M -1.97M

Balance Sheet Statement

Balance Sheet Statement history of Rua Bioscience Limited (NZX:RUA)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Cash 1.9M 3.36M 3.94M 4.17M
Short Term Investments 8.04M 13.04M - 2M
Net Receivables 543.8k 604.24k 777.44k 301.17k
Inventory 218.81k - - -
Other Current Assets 526.52k 1.68k 23.4k -
Total Current Assets 11.39M 17.12M 4.82M 6.47M
Property Plant Equipment 6.64M 7.1M 5.91M 645.62k
Good Will 10.45M 4M 4M 4M
Intangible Assets 5.02M - - -
Other Assets 75k 2.63M 995.46k 13.69k
Total Assets 33.57M 30.85M 15.73M 11.13M
Accounts Payable 317.43k 453.39k 512.01k 175.32k
Other Current Liab 3.95M 56.78k 91.64k -
Other Liab 3.82M 31.91k 124.86k -
Total Current Liabilities 4.86M 1.18M 998.61k 469.79k
Total Liab 9.38M 2.02M 1.33M 621.56k
Common Stock 41.89M 37.42M 18.92M 12.48M
Retained Earnings -17.84M -9.2M -4.78M -1.97M
Treasury Stock 141.69k 614.77k 260.31k -
Other Stockholder Equity 141.69k 614.77k 260.31k -
Total Stockholder Equity 24.2M 28.83M 14.4M 10.51M
Net Tangible Assets 8.73M 24.83M 10.4M 6.51M
Long Term Debt - - 10.76k 49.85k

Cash Flow Statement

Cash Flow Statement history of Rua Bioscience Limited (NZX:RUA)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Net Income -8.64M -4.42M -2.81M -1.97M
Depreciation 814.47k 694.6k 214.81k 47.37k
Change To Netincome 930.36k -1.3M -405.76k -67.43k
Change To Account Receivables 99.12k 370.45k -708.83k -265.87k
Change To Liabilities 14.9k 168.4k 141.46k 158.07k
Change To Inventory -237.59k -237.59k -237.59k -237.59k
Change To Operating Activities 169.88k 35.93k -56.45k 143.85k
Total Cash From Operating Activities -6.84M -4.45M -3.63M -1.95M
Capital Expenditures -400.1k -1.4M -5.02M -455.08k
Investments 5M -13.12M 2M -2M
Other Cashflows From Investing Activities 113.36k 69.28k 47.62k 21.18k
Total Cashflows From Investing Activities 5.59M -14.43M -2.97M -2.43M
Net Borrowings -164.05k -161.08k -64.16k 83.02k
Other Cashflows From Financing Activities -44.59k -1.54M -573.95k -513.79k
Total Cash From Financing Activities -208.64k 18.3M 6.36M 8.56M
Change In Cash -1.46M -578.02k -235.62k 4.17M
Dividends Paid - - - -